期刊文献+

肺癌组织CD44、CD71的检测及与病理学的关系 被引量:2

Relationship between expression of CD44, CD71 in lung cancer tissue and its pathology
下载PDF
导出
摘要 目的了解肺癌组织CD44、CD71的表达与病理学的关系。方法应用流式细胞术对53例肺癌患者癌组织的CD44、CD71进行检测,并与其组织细胞学分类、分型,年龄,淋巴结转移等进行分析。结果CD44、CD71在低分化肿瘤细胞的表达明显高于中、高分化肿瘤细胞;肺肿瘤发生淋巴转移时,其CD44的表达明显增高,60岁以下患者CD71表达率明显高于60岁以上的患者。结论肺癌组织CD44的表达与肿瘤细胞的分化程度、淋巴结转移有关,CD71的表达与肿瘤细胞的分化程度、患者的年龄有关。 Objective To study relationship between expression of CD44, CD71 in lung cancer tissue and its pathology.Methods Expression of CD44 and CD71 of cancer tissue in 53 patients with lung cancer were measured by flow cytometer and the relations among its tissue cytology, age, lymphoid metastatic status were analyzed. Results Expression of CD44 and CD71 in low differentiation cancer cell were evidenly higher than those in moderate and high differentiation cancer cell. At the time of lymphoid metastatic status in patients with lung cancer, its expression of CD44 were on the remarkable increase, and expression of CD71 in patients with no more than 60 years old were notably higher than those in patients with more than 60 years old. Conclusion Expression of CD44 of lung cancer tissue were relevant to the differentiation degree of tumor cell and lymphoid metastatic status, however expression of CD71 were relevant to the differentiation degree of tumor cell and the age of patients.
出处 《实用肿瘤学杂志》 CAS 2006年第4期268-269,355,共3页 Practical Oncology Journal
关键词 肺癌 抗原 CD44 CD71 病理学 Lung cancer CD44 CD71 Pathology
  • 相关文献

参考文献6

二级参考文献25

  • 1杨云生,陈继昌.大肠癌细胞转铁蛋白受体表达的临床意义[J].癌症,1994,13(5):402-404. 被引量:1
  • 2朱英桂,柳凤轩,贺光友,付晓岚.膀胱移行细胞癌核DNA含量检测及其与预后关系的探讨[J].第三军医大学学报,1994,16(4):259-262. 被引量:1
  • 3Okabe-Kado J, Kasukabe T, Honma Y, et al. Identity of a differentiation inhibiting factor for mouse myeloid leukemia cells with nm23/nucleoside diphosphate kinase [J]. Biochem Biophys Res Commun,1992,182 (3): 987-- 994.
  • 4Okabe-Kado J. Factors inhibiting differentiation of myeloid leukemia cells [J]. Crit Rev Oncog, 1992,3(3):293--319.
  • 5Yokoyama A,Okabe-Kado J,Wakimoto N,et al. Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies [J]. Blood, 1998,91 (6) : 1845--1851.
  • 6Jalkanen S, Bargatze RF, Toyos J, et al. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95 KD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells [J]. J Cell Biol, 1987,105(2):983--990.
  • 7Harris NL, Jeffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms:a proposal from the International Lymphoma Study Group [J]. Blood, 1994,84(5) :1361--1390.
  • 8Steeg PS, Bevilacqua G, Kopper L, et al. Evidence for a novel gene associated with low tumor metastatic potential [J]. J Natl Cancer Inst, 1988,80(3): 200--204.
  • 9Freije JM, MacDonald NJ, Steeg PS. nm23 and tumor metastasis: basic and translational advances [J].Biochem Soc Symp, 1998,63 (2) : 261 -- 271.
  • 10Venturelli D, Martinez R, Melotti P, et al. Overexpression of DR-nm23, a protein encoded by a member of the nm23 gene family, inhibits granulocyte differentiation and induces apoptosis in 32Dc13 myeloid cells [J]. Proc Natl Acad Sci USA, 1995,92(16):7435--7439.

共引文献12

同被引文献12

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部